InvestorsHub Logo
icon url

$heff

05/16/16 3:01 AM

#93950 RE: $heff #92457

$RIGL.. $103m cash runway thru 3Q17. Two P3 fostamatinib trials in ITP, P2s in IgAN & in AI hemolytic anemia (no approved tx) all data by EY16. (H/t @mgoodma)